(Q37761328)

22 August 2017

1 reference

title

New therapeutic approaches to resistant hypertension (English)

1 reference

22 August 2017

main subject

arterial hypertension

0 references

2

Henry Krum

1 reference

22 August 2017

Markus P Schlaich

1

1 reference

22 August 2017

Murray D Esler

series ordinal

3

1 reference

22 August 2017

publication date

1 August 2010

1 reference

Current Hypertension Reports

22 August 2017

published in

1 reference

22 August 2017

volume

12

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

296-302

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-010-0119-1

22 August 2017

exact match

0 references

cites work

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-010-0119-1

Renal afferent denervation prevents hypertension in rats with chronic renal failure

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-010-0119-1

Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension

21 January 2018

1 reference

12 December 2020

Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity

1 reference

12 December 2020

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

12 December 2020

A limited renal injury may cause a permanent form of neurogenic hypertension.

1 reference

12 December 2020

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

1 reference

12 December 2020

Implantable carotid sinus stimulator for the treatment of resistant hypertension: local effects on carotid artery morphology

1 reference

12 December 2020

Aliskiren combined with losartan in type 2 diabetes and nephropathy

1 reference

12 December 2020

Prolonged activation of the baroreflex produces sustained hypotension.

1 reference

12 December 2020

Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects

1 reference

12 December 2020

Vasopeptidase inhibitors

1 reference

12 December 2020

Aliskiren: a review of its use in the management of hypertension

1 reference

12 December 2020

Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage

1 reference

12 December 2020

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

1 reference

12 December 2020

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

1 reference

12 December 2020

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity

1 reference

12 December 2020

Neurogenic factors and hypertension in chronic renal failure

1 reference

12 December 2020

Chronic baroreflex activation by the Rheos system: an overview of results from European and North American feasibility studies

1 reference

12 December 2020

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

1 reference

12 December 2020

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

1 reference

12 December 2020

An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.

1 reference

12 December 2020

Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study

1 reference

12 December 2020

Resistant hypertension: an overview of evaluation and treatment

1 reference

12 December 2020

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

12 December 2020

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

1 reference

12 December 2020

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

1 reference

12 December 2020

2007 Guidelines for the Management of Arterial Hypertension

1 reference

12 December 2020

Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.

1 reference

12 December 2020

Renal sympathetic-nerve ablation for uncontrolled hypertension

1 reference

12 December 2020

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

1 reference

12 December 2020

Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept

1 reference

12 December 2020

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

1 reference

12 December 2020

Cost-effectiveness of treating resistant hypertension with an implantable carotid body stimulator

1 reference

12 December 2020

Efficacy of spironolactone therapy in patients with true resistant hypertension.

1 reference

12 December 2020

Neurogenic factors and hypertension in renal disease.

1 reference

12 December 2020

Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients.

1 reference

12 December 2020

Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis

1 reference

12 December 2020

The burden of blood pressure-related disease: a neglected priority for global health

1 reference

12 December 2020

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy

1 reference

12 December 2020

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Sympathectomy in the treatment of hypertension; review of 122 cases

1 reference

12 December 2020

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure

1 reference

12 December 2020

Splanchnicectomy for essential hypertension; results in 1,266 cases

1 reference

12 December 2020

Effect of spironolactone on blood pressure in subjects with resistant hypertension

1 reference

12 December 2020

Structure-based design of aliskiren, a novel orally effective renin inhibitor

1 reference

12 December 2020

10.1007/S11906-010-0119-1

Identifiers

DOI

1 reference

22 August 2017

1 reference